President Trump signed an executive order reclassifying the federal status of marijuana, categorizing it as a drug with less potential for harm and dependence. It’s a major shift in policy that could have wide-ranging effects on cannabis use and research. William Brangham discussed more with Beau Kilmer of the RAND Drug Policy Research Center.
